Modelling the Relative Vaccine Efficacy of ARCT-154, a Self-Amplifying mRNA COVID-19 Vaccine, versus BNT162b2 Using Immunogenicity Data

Văn Hùng Nguyễn(McGill University Health Centre), Joaquin Mould-Quevedo(Seqirus (United States)), Aimee Ferraro(Seqirus (United States)), Sankarasubramanian Rajaram(Seqirus (United Kingdom)), John Youhanna(Seqirus (United States)), Pascal Crépey(Centre National de la Recherche Scientifique), Cheng Chang(Beihua University), Josephine van Boxmeer, Jean Marie Pivette(MNM Consulting (France)), Ethan C. Settembre
Vaccines
October 11, 2024
Cited by 2


Related Papers